NDC 70771-1592

ATAZANAVIR

Atazanavir

ATAZANAVIR is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Zydus Lifesciences Limited. The primary component is Atazanavir Sulfate.

Product ID70771-1592_7d41e669-d7c9-44b9-9470-793e56fa1776
NDC70771-1592
Product TypeHuman Prescription Drug
Proprietary NameATAZANAVIR
Generic NameAtazanavir
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2021-05-04
Marketing CategoryANDA /
Application NumberANDA210575
Labeler NameZydus Lifesciences Limited
Substance NameATAZANAVIR SULFATE
Active Ingredient Strength200 mg/1
Pharm ClassesCytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 70771-1592-1

100 CAPSULE in 1 BOTTLE (70771-1592-1)
Marketing Start Date2021-05-04
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "ATAZANAVIR" or generic name "Atazanavir"

NDCBrand NameGeneric Name
31722-653AtazanavirAtazanavir
31722-654AtazanavirAtazanavir
31722-655AtazanavirAtazanavir
42385-920AtazanavirAtazanavir
42385-921AtazanavirAtazanavir
42385-922AtazanavirAtazanavir
59762-0408ATAZANAVIRATAZANAVIR
59762-0409ATAZANAVIRATAZANAVIR
59762-0410ATAZANAVIRATAZANAVIR
69097-446ATAZANAVIRATAZANAVIR
69097-443ATAZANAVIRATAZANAVIR
69097-444ATAZANAVIRATAZANAVIR
69097-445ATAZANAVIRATAZANAVIR
69238-1135AtazanavirAtazanavir
69238-1136AtazanavirAtazanavir
69238-1137AtazanavirAtazanavir
69238-1138AtazanavirAtazanavir
70518-2832ATAZANAVIRATAZANAVIR
0904-6875Atazanavir SulfateAtazanavir
16714-860Atazanavir SulfateAtazanavir
16714-861Atazanavir SulfateAtazanavir
16714-862Atazanavir SulfateAtazanavir
60687-399Atazanavir SulfateAtazanavir
65862-710Atazanavir SulfateAtazanavir
65862-711Atazanavir SulfateAtazanavir
0003-3622REYATAZATAZANAVIR
0003-3624REYATAZATAZANAVIR
0003-3631REYATAZATAZANAVIR
0003-3638REYATAZATAZANAVIR
50090-1007REYATAZATAZANAVIR
50090-1581REYATAZATAZANAVIR
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.